This article is a correction to:
Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer
Lin Wang1
Xiang-Bo Ji2Li-Hong Wang2Jian-Ge Qiu1Feng-Mei Zhou1Wen-Jing Liu3Di-di Wan2Marie Chai-mi Lin1Ling-Zhi Liu4Jian-Ying Zhang2*
Bing-Hua Jiang1,4*- 1The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China
- 2BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China
- 3Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, China
- 4Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, United States
A Corrigendum on
Regulation of microRNA-497- targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer
by Wang, L., Ji, X.-B., Wang, L.-H., Qiu, J.-G., Zhou, F.-M., Liu, W.-J., Wan, D., Lin, M. C., Liu, L.-Z., Zhang, J.-Y., and Jiang, B.-H. (2020). Front. Cell Dev. Biol. 8:840. doi: 10.3389/fcell.2020.00840
In the published article, there was a mistake in the Author Contributions. The author L-ZL was accidentally included in the contribution, “performed qRT-PCR assay, reporter assay and immunoblotting analysis, analyzed chemosensitivity array and animal analysis”, and for authors LW, L-ZL, J-YZ, and B-HJ the contribution “designed the project and revised the manuscript” was accidentally omitted.
The correct Author Contributions appear below:
“LW, X-BJ, and L-HW performed experiments, analyzed data, and wrote the manuscript. J-GQ, W-JL, DW, F-MZ, and ML performed qRT-PCR assay, reporter assay and immunoblotting analysis, analyzed chemosensitivity array and animal analysis. LW, L-ZL, J-YZ, and B-HJ designed the project and revised the manuscript. All authors approved the submitted version.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: MiR-497, Akt2, tumor growth, chemoresistance, NSCLC
Citation: Wang L, Ji X-B, Wang L-H, Qiu J-G, Zhou F-M, Liu W-J, Wan D-d, Lin MC-m, Liu L-Z, Zhang J-Y and Jiang B-H (2022) Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer. Front. Cell Dev. Biol. 10:1008088. doi: 10.3389/fcell.2022.1008088
Received: 31 July 2022; Accepted: 05 August 2022;
Published: 23 September 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Wang, Ji, Wang, Qiu, Zhou, Liu, Wan, Lin, Liu, Zhang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bing-Hua Jiang, binghjiang@yahoo.com; Jian-Ying Zhang, jianyingzhang@hotmail.com